These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 17204262)
1. Cytochemical analysis of storage materials in cultured skin fibroblasts from patients with I-cell disease. Kawashima I; Ohsawa M; Fukushige T; Nagayama Y; Niida Y; Kotani M; Tajima Y; Kanekura T; Kanzaki T; Sakuraba H Clin Chim Acta; 2007 Mar; 378(1-2):142-6. PubMed ID: 17204262 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies. Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574 [TBL] [Abstract][Full Text] [Related]
3. The subcellular localization of soluble and membrane-bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical study. van Dongen JM; Willemsen R; Ginns EI; Sips HJ; Tager JM; Barranger JA; Reuser AJ Eur J Cell Biol; 1985 Nov; 39(1):179-89. PubMed ID: 2935398 [TBL] [Abstract][Full Text] [Related]
4. Cytochemical and biochemical detection of intracellularly accumulated sialyl glycoconjugates in sialidosis and galactosialidosis fibroblasts with Macckia amurensis. Kotani M; Yamada H; Sakuraba H Clin Chim Acta; 2004 Jun; 344(1-2):131-5. PubMed ID: 15149881 [TBL] [Abstract][Full Text] [Related]
5. Characterization of storage material in cultured fibroblasts by specific lectin binding in lysosomal storage diseases. Virtanen I; Ekblom P; Laurila P; Nordling S; Raivio KO; Aula P Pediatr Res; 1980 Nov; 14(11):1199-1203. PubMed ID: 7454432 [TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical localization of lysosomal acid phosphatase in normal and "I-cell" fibroblasts. Parenti G; Willemsen R; Hoogeveen AT; Verleun-Mooyman M; Van Dongen JM; Galjaard H Eur J Cell Biol; 1987 Feb; 43(1):121-7. PubMed ID: 3552677 [TBL] [Abstract][Full Text] [Related]
14. Lysosomal integral membrane glycoproteins are expressed at high levels in the inclusion bodies of I-cell disease fibroblasts. Sandoval IV; Chen JW; Yuan L; August JT Arch Biochem Biophys; 1989 May; 271(1):157-67. PubMed ID: 2540710 [TBL] [Abstract][Full Text] [Related]
15. Identification of plasma membrane associated mature beta-hexosaminidase A, active towards GM2 ganglioside, in human fibroblasts. Mencarelli S; Cavalieri C; Magini A; Tancini B; Basso L; Lemansky P; Hasilik A; Li YT; Chigorno V; Orlacchio A; Emiliani C; Sonnino S FEBS Lett; 2005 Oct; 579(25):5501-6. PubMed ID: 16212960 [TBL] [Abstract][Full Text] [Related]
16. Decreased apoptotic response of inclusion-cell disease fibroblasts: a consequence of lysosomal enzyme missorting? Terman A; Neuzil J; Kågedal K; Ollinger K; Brunk UT Exp Cell Res; 2002 Mar; 274(1):9-15. PubMed ID: 11855852 [TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of mucolipidosis II--electron microscopy and biochemical evaluation. Carey WF; Jaunzems A; Richardson M; Fong BA; Chin SJ; Nelson PV Prenat Diagn; 1999 Mar; 19(3):252-6. PubMed ID: 10210124 [TBL] [Abstract][Full Text] [Related]
18. Electron microscopic findings in skin biopsies from patients with Danon disease. Alroy J; Pfannl R; Slavov D; Taylor MR Ultrastruct Pathol; 2010 Dec; 34(6):333-6. PubMed ID: 21070164 [TBL] [Abstract][Full Text] [Related]
20. Lysosomal exocytosis is impaired in mucolipidosis type IV. LaPlante JM; Sun M; Falardeau J; Dai D; Brown EM; Slaugenhaupt SA; Vassilev PM Mol Genet Metab; 2006 Dec; 89(4):339-48. PubMed ID: 16914343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]